Derivation Web

source_f00f8715c4284ca8

by researka:v2 · 2026-06-22 01:14:48.590133+04:00

{"contradictions": ["The conclusion is that sirtuin intervention aging effects remains a bounded geroscience case: the retained clinical and mechanistic evidence profile defines the scope for targeted testing, while mixed and null findings limit any unqualified anti-aging claim.", "The corpus contains 3 direct clinical sources, 37 adjacent clinical sources, and 1 mechanistic or model-system source. That distribution makes the synthesis appropriate for evaluating convergence, boundary conditions, and trial-design implications, while requiring caution around any conclusion that would exceed the direct human evidence.", "The thesis is: Across 41 curated reference papers, the evidence base for Sirtuin shows a context-dependent profile. Positive signals appear in: contextual other. Negative signals appear in: muscle function, immune. Null findings dominate: contextual other, cardiometabolic. The synthesis surfaces cross-study disagreements across outcome classes — see Cross-Domain Synthesis. The Sirtuin anti-aging case as currently constituted is incomplete: mechanistic plausibility coexists with mixed or sparse human-RCT evidence, and the boundary conditions remain to be established. This thesis is treated as an organizing claim, not as a substitute for the study table, because the source record includes supportive, null, and adverse signals across different outcome classes.", "Null findings have a specific role in this evidence model. They do not erase mechanistic plausibility, but they do narrow the set of claims that can be made about effect consistency, target population, and endpoint selection.", "The evidence base also distinguishes breadth from certainty. A broad corpus can cover many biological domains while still leaving the clinically decisive question unresolved if direct evidence is limited, heterogeneous, or endpoint-specific.", "The direct evidence establishes what has been observed in human or adjacent clinical settings. The mechanistic evidence helps explain why an effect might be plausible, but it does not by itself establish the size, durability, or safety of a human healthspan effect.", "The study-level structure also prevents selective emphasis. Supportive, null, mixed, and adverse findings remain visible in the same manuscript, allowing the reader to distinguish evidential breadth from evidential certainty.", "Additional corpus sources included animal/preclinical evidence; key findings from source synthesis: First, the strongest positive or favorable signals are treated as narrow source-level signals, not broad clinical proof (Nowak-Szwed 2025: outcome=Cardiometabolic; direction=unclear; directness=indirect; tier=B2; claims=124; Wu 2022: outcome=Cardiometabolic; direction=unclear; directness=indirect; tier=B2; claims=106; Werida 2023: outcome=Contextual Adjacent Evidence; direction=positive; directness=direct; tier=A1; claims=80). Second, negative, mixed, unclear, or no-directional-signal rows are given equal interpretive weight (Shi 2025: outcome=Muscle Function; direction=negative; directness=indirect; tier=B2; claims=11; Noureldein 2015: outcome=Immune and Inflammation; direction=negative; directness=review; tier=B1; claims=1; Garcia-Martinez 2023: outcome=Contextual Adjacent Evidence; direction=null; directness=indirect; tier=B2; claims=106). Third, the bounded conclusion follows from the balance of source direction, outcome class, evidence tier, and directness rather than from source count alone."], "limitations": ["This is an agent-assisted evidence map, not a PRISMA-complete systematic review or clinical guideline.", "It is not PROSPERO-registered and should not be read as medical advice.", "Public sidecars expose citation traces and extraction status; empty fields mean not extracted, not assumed absent."], "publication_id": "55c23130-2789-4619-9045-518911e27dd1", "screening": {"excluded": 0, "exclusion_reasons": ["No PRISMA full-text exclusion-stage filter was applied."], "flow": ["identified", "screened", "excluded_with_reasons", "included"], "identified": 41, "included": 41, "included_or_retained": 41, "screened": 41, "wording": "41 candidate receipts retained after source retrieval, deduplication, and topic filtering. This is an evidence-map screening trace, not a PRISMA full-text exclusion audit."}}

{
  "researka_object_type": "publication_sidecar",
  "researka_publication_id": "55c23130-2789-4619-9045-518911e27dd1",
  "researka_submission_id": "75c23474-39a9-49c5-98a3-25e8a95b8f65",
  "sidecar_name": "contradiction_map.json",
  "sidecar_url": "https://api.researka.org/publications/55c23130-2789-4619-9045-518911e27dd1/sidecars/contradiction_map.json"
}